BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33710383)

  • 1. Differentiation between renal oncocytomas and chromophobe renal cell carcinomas using dynamic contrast-enhanced computed tomography.
    Guo K; Ren S; Cao Y; Zhang H; Zhang Y; Gu X; Wang Z
    Abdom Radiol (NY); 2021 Jul; 46(7):3309-3316. PubMed ID: 33710383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aorta-Lesion-Attenuation-Difference (ALAD) on contrast-enhanced CT: a potential imaging biomarker for differentiating malignant from benign oncocytic neoplasms.
    Dhyani M; Grajo JR; Rodriguez D; Chen Z; Feldman A; Tambouret R; Gervais DA; Arellano RS; Hahn PF; Samir AE
    Abdom Radiol (NY); 2017 Jun; 42(6):1734-1743. PubMed ID: 28197683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
    Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
    Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of renal oncocytoma and chromophobe renal cell carcinoma using CT features: a central scar-matched retrospective study.
    Li X; Nie P; Zhang J; Hou F; Ma Q; Cui J
    Acta Radiol; 2022 Feb; 63(2):253-260. PubMed ID: 33497276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
    Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
    Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
    Wu J; Zhu Q; Zhu W; Chen W; Wang S
    Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
    Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
    Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study.
    Li X; Ma Q; Nie P; Zheng Y; Dong C; Xu W
    Br J Radiol; 2022 Jan; 95(1129):20210534. PubMed ID: 34735296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of mult-detector CT for papillary renal cell carcinoma and chromophobe renal cell carcinoma].
    Liu X; Zou X; Chen H; Fang X; Hu X; Sun R
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):52-6. PubMed ID: 25877320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to differentiate benign from malignant renal masses.
    Kahn AE; Lomax SJ; Bajalia EM; Ball CT; Thiel DD
    Can J Urol; 2020 Aug; 27(4):10278-10284. PubMed ID: 32861252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram predictive model for differentiation between renal oncocytoma and chromophobe renal cell carcinoma at multi-phasic CT: a retrospective study.
    Elsayed Sharaf D; Shebel H; El-Diasty T; Osman Y; Khater SM; Abdelhamid M; Abou El Atta HM
    Clin Radiol; 2022 Oct; 77(10):767-775. PubMed ID: 35764438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
    Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
    World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
    Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
    Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of radiomics in differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Li Y; Huang X; Xia Y; Long L
    Abdom Radiol (NY); 2020 Oct; 45(10):3193-3201. PubMed ID: 31664486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
    Zokalj I; Marotti M; Kolarić B
    Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.